About
MasterSwitch Bio is developing a modified mRNA therapy that targets the transcription factor HNF4α to restore liver function in patients with End Stage Liver Disease and cirrhosis by upregulating key hepatocyte proteins.
Explore MasterSwitch Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.